A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
NCT00969410
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Malignant Solid Tumour
Liver Metastases
Interventions
BIOLOGICAL:
AV-299
Sponsor
AVEO Pharmaceuticals, Inc.